Literature DB >> 27865116

Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.

Sanjeewa Kularatna1, Joshua Byrnes2, Yih Kai Chan3, Melinda J Carrington3, Simon Stewart3, Paul A Scuffham4.   

Abstract

BACKGROUND: The EQ-5D-3L, a generic multi-attribute utility instrument (MAUI), is widely employed to assist in economic evaluations in health care. The EQ-5D-3L lacks sensitivity when used in conditions such as cardiovascular disease (CVD). Although there are number of CVD specific quality of life instruments, currently, there are no CVD specific MAUIs. The aim of this study is to investigate the discriminative ability and responsiveness of the EQ-5D-3L and the Minnesota Living with Heart Failure Questionnaire (MLHF), a CVD specific quality of life instrument in a group of heart failure patients.
METHODS: The psychometric performance of the EQ-5D-3L and the MLHF was assessed using data from a randomised trial for a heart failure management intervention. The two instruments were compared for discrimination, responsiveness and agreement. The severity groups were defined using New York Heart Association functional classes.
RESULTS: The effect sizes for severe classes were generally similar showing good discrimination. The MLHF recorded better responsiveness between the time points than the EQ-5D-3L which was indicated by higher effect sizes and standardised response means. The change in MLHF summary scores between the time points was significant (p<0.005; paired t-test). The overall agreement between the two measures was low.
CONCLUSION: The low correlation indicates that the two classification systems cover different aspects of health space. Comparison of CVD specific instruments with other generic MAUIs such as EQ-5D-3L and AQOL-8D is recommended for further research.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  EQ-5D; MLHF; QALY; Quality of life; Utility

Mesh:

Year:  2016        PMID: 27865116     DOI: 10.1016/j.ijcard.2016.11.030

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Special Edition on Utility Measurement, PharmacoEconomics.

Authors:  Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

2.  Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument.

Authors:  Sanjeewa Kularatna; Donna Rowen; Clara Mukuria; Steven McPhail; Gang Chen; Brendan Mulhern; Jennifer A Whitty; Joshua Byrnes; Paul Scuffham; John Atherton; Stefan Höfer; William Parsonage
Journal:  Qual Life Res       Date:  2021-05-26       Impact factor: 4.147

Review 3.  Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.

Authors:  Jenny Rankin; Donna Rowen; Amanda Howe; John G F Cleland; Jennifer A Whitty
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

4.  Health State Utilities of Patients with Heart Failure: A Systematic Literature Review.

Authors:  Gian Luca Di Tanna; Michael Urbich; Heidi S Wirtz; Barbara Potrata; Marieke Heisen; Craig Bennison; John Brazier; Gary Globe
Journal:  Pharmacoeconomics       Date:  2020-11-30       Impact factor: 4.981

5.  Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: the NORDLAND study, a randomized trial.

Authors:  Antonio Lopez-Villegas; Daniel Catalan-Matamoros; Remedios Lopez-Liria; Terje Enebakk; Hilde Thunhaug; Knut Tore Lappegård
Journal:  BMC Geriatr       Date:  2018-09-21       Impact factor: 3.921

6.  The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.

Authors:  Hasnain M Dalal; Rod S Taylor; Kate Jolly; Russell C Davis; Patrick Doherty; Jackie Miles; Robin van Lingen; Fiona C Warren; Colin Green; Jennifer Wingham; Colin Greaves; Susannah Sadler; Melvyn Hillsdon; Charles Abraham; Nicky Britten; Julia Frost; Sally Singh; Christopher Hayward; Victoria Eyre; Kevin Paul; Chim C Lang; Karen Smith
Journal:  Eur J Prev Cardiol       Date:  2018-10-10       Impact factor: 7.804

7.  Cost and health effects of case management compared with outpatient clinic follow-up in a Dutch heart failure cohort.

Authors:  Henk van Voorst; Alfred Ernest Reiner Arnold
Journal:  ESC Heart Fail       Date:  2020-04-16

8.  Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures.

Authors:  Hasnain Dalal; Rod S Taylor; John G Cleland
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.